Featured

Research co-led by the University of Queensland has found that Australia is falling short of similar countries when it comes to funding basic research, specifically in the medical, biotechnology, and pharmaceutical arenas. The University of Queenland’s School of Chemical...

In December, the European Commission went on to issue the first approval when it comes to allogenic T-cell therapy in the world, which happened to be a prominent milestone when it comes to the cell and gene therapy sector....

Drug shortages endanger national security as well as public health. This is the conclusion of a new report from the United States Senate's Homeland Security Committee. As per the report, medicine shortages reached a five-year high of 295 in 2022,...

The global cell and gene therapy (CGT) supply chain and logistics industry is predicted to reach $3.12 billion by 2031, based on a market report. This equates to a very promising compound annual growth rate (CAGR) of 11.2% between 2023...

Like every other consumer packaged market, pharmaceuticals has also gone on to experience a reckoning with its ecological footprint, mostly in the more consumer-facing element of packaging. It is well to be noted that consumer preferences as well as governmental...

Adjupanrix, a pandemic influenza vaccine (split virion, inactivated, adjuvanted) manufactured by GSK, has been reserved for future manufacturing and supply under a framework agreement with the European Commission's (EC) Health Emergency Preparedness and Response Authority (HERA). Influenza pandemics, which are caused...

A third workplan with measures due by 2025 has been released by the joint Big Data Steering Group of the European Medicines Agency (EMA) as well as the Heads of Medicines Agencies (HMA). The new strategy, according to EMA, will...